Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins

Although membranous nephropathy (MN) is a commonly observed cause of post‐transplant glomerulonephritis, distinguishing de novo from recurrent MN in kidney allograft is often difficult. Phospholipase A2 receptor (PLA2R) staining is useful for diagnosing recurrent MN in allografts similarly to idiopathic MN in native kidney. No specific treatment strategy has been established for MN, especially when accompanied with HCV infection in kidney transplant recipients. This report describes a 66‐year‐old man who was diagnosed as having PLA2R positive membranous nephropathy accompanied with already‐known IgA nephropathy and HCV infection 26 years after kidney transplantation conducted between identical twins. PLA2R was detected along capillary loops, implying that this patient is affected by the same pathogenic mechanism as idiopathic MN, not secondary MN associated with other disorders such as HCV infection. The patient successfully achieved clinical remission after steroid therapy.

[1]  V. Tesar,et al.  Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  P. Walker,et al.  Phospholipase A2 Receptor (PLA2R) Staining Is Useful in the Determination of De Novo Versus Recurrent Membranous Glomerulopathy , 2013, Transplantation.

[3]  C. Ponticelli,et al.  De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease? , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  G. U. Okyay,et al.  Remission of De Novo Membranous Nephropathy in a Kidney Allograft Recipient: a Case Report , 2012, Renal failure.

[5]  M. Troxell,et al.  Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts. , 2011, Transplantation proceedings.

[6]  K. Nitta,et al.  De novo membranous nephropathy and antibody‐mediated rejection in transplanted kidney , 2011, Clinical transplantation.

[7]  M. Arafah,et al.  Nasopharyngeal T-cell monomorphic posttransplant lymphoproliferative disorders and combined IgA nephropathy and membranous glomerulonephritis in a patient with renal transplantation: a case report with literature review. , 2010, Transplantation proceedings.

[8]  克治 桑門 海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .

[9]  P. D'Athis,et al.  Recurent and de novo membranous glomerulopathy after kidney transplantation. , 2009, Transplantation proceedings.

[10]  M. Josephson,et al.  Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. , 2003, Seminars in nephrology.

[11]  A. Kandus,et al.  Recurrent immunoglobulin A nephropathy complicated with de novo membranous glomerulonephritis in renal allografts. , 2002, Transplantation proceedings.

[12]  R. Ouseph,et al.  Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). , 1999, Transplantation.

[13]  J. Morales,et al.  Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. , 1997, Transplantation.

[14]  A. Schwarz,et al.  IMPACT OF DE NOVO MEMBRANOUS GLOMERULONEPHRITIS ON THE CLINICAL COURSE AFTER KIDNEY TRANSPLANTATION , 1994, Transplantation.